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We report our experience with atrial pacing as treatment for
PLE in patients undergoing the Fontan operation who mani-
fest sinus node dysfunction.
Clinical summaries
PATIENT 1. The patient underwent a nonfenestrated lateral
tunnel Fontan operation for tricuspid atresia, ventricular sep-
tal defect, and pulmonic stenosis without complications at 2
years of age. Four years later, the patient had PLE with ascites
and diarrhea (total protein, 4.3 g/dL; albumin, 2.5 g/dL; 24°
stool α-1 antitrypsin clearance, 166 mL).* Temporary
improvement occurred with diuretics, supplemental albumin
infusions, and corticosteroids. The patient was unable to be
weaned off of steroids after a return of PLE. Cardiac catheter-
ization revealed a mean right atrial pressure of 13 mm Hg, an
unobstructed systemic venous pathway, and good ventricular
function. One year later, the patient underwent surgical cre-
ation of a single 4.8-mm fenestration. The oxygen saturation
decreased to 84% with resolution of PLE (total protein, 7.2
g/dL; albumin, 4.1 g/dL). An ambulatory monitor 2 years later
revealed a predominant junctional rhythm at 65 beats/min.
The patient continued to do well (oxygen saturation, 85%) on
Protein-losing enteropathy (PLE) is an uncommon but
potentially debilitating and difficult to manage complication
after the Fontan operation. A number of treatment strategies,
including diuretics, afterload reduction, intravenous albumin
replacement, corticosteroids, heparin, creation of a fenestra-
tion, or revision of the Fontan pathway, have all been attempt-
ed, with various degrees of success.1-4 Baffle fenestration is
believed to augment cardiac output and increase oxygen
delivery while lowering central venous pressure. Resolution
of PLE after fenestration creation suggests that improvement
in cardiac output and oxygen delivery are the key elements
necessary for successful treatment of this disorder.
Another complication noted after the Fontan operation is
sinus node dysfunction.5 The presence of junctional rhythm
and loss of atrioventricular synchrony can have deleterious
effects on Fontan physiology by diminishing cardiac output.
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*Normal laboratory values: total protein, 5.9 to 7.0 g/dL; albumin,
3.5 to 5.2 g/dL; and 24° stool α-1 antitrypsin clearance, 27 mL or
less.
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minimal diuretics and afterload reduction until the following
year, when there was return of diarrhea, ascites, and perior-
bital edema (total protein, 3.7 g/dL; albumin, 1.8 g/dL).
Repeat cardiac catheterization identified mild narrowing in
the Fontan baffle, which was corrected with stent placement.
With temporary atrial pacing in the cardiac catheterization
laboratory, the systemic blood flow increased from 2.8 to 3.2
L · min–1 · m–2. Symptoms of PLE persisted despite correc-
tion of the anatomic baffle narrowing. The patient subse-
quently underwent placement of an epicardial single-chamber
pacemaker (Medtronic Thera 7960, Medtronic, Inc,
Minneapolis, Minn) programmed at AAI 80 pulsations/min.
Within 3 weeks, there was complete resolution of PLE. Six
months later, the patient continues to be well without any
edema or diarrhea (total protein, 7.2 g/dL; albumin, 4.3 g/dL).
PATIENT 2. The patient was admitted with hypoproteinemia,
edema, and ascites 11 months after an extracardiac fenestrat-
ed Fontan operation for hypoplastic left heart syndrome (total
protein, 4.4 g/dL; albumin, 2.1 g/dL; and 24° stool α-1 anti-
trypsin clearance, 52 mL). Temporary relief was achieved
with intravenous diuretic therapy and albumin replacement.
The patient was readmitted twice within a 12-month span for
25% albumin infusions. Intra-atrial re-entrant tachycardia
was observed within the first few months after the Fontan
operation. Adequate control of the arrhythmia was achieved
on a combination of digoxin and amiodarone; however,
marked junctional bradycardia followed 6 months later.
Cardiac catheterization revealed a right atrial pressure of 10
mm Hg, an end-diastolic pressure of 5 mm Hg, and an arter-
ial oxygen saturation of 96%. The cardiac index was 3.2 L ·
min–1 · m–2, with no evidence of conduit obstruction or pul-
monary artery distortion. Because of persistent sinus node
dysfunction, a single-chamber epicardial pacemaker was
implanted (AAI at 80 pulsations/min; Medtronic Kappa 701)
2 years after the Fontan operation. Within 3 weeks, the diar-
rhea resolved, and the patient has remained free of ascites,
diarrhea, and peripheral edema (total protein, 7.2 g/dL; albu-
min, 4.4 g/dL). 
Discussion. Enteric loss of proteins with the clinical find-
ings of diarrhea, edema, ascites, immunodeficiency, and/or
hypercoagulabilty is diagnosed with increasing frequency
after the Fontan operation. The exact pathophysiologic mech-
anism is unknown, but it is likely related to a hemodynamic
derangement of the intestinal circulation secondary to the
Fontan physiology. As is typical in other patients with PLE,
the 2 patients in this report presented at variable times after
the Fontan operation (range, 1-4 years). Although both
patients had some initial improvement with diuretic therapy
and afterload reduction, symptoms of PLE returned. At our
institution, all patients with PLE undergo a cardiac catheteri-
zation to exclude baffle obstruction or significant pulmonary
artery distortion as a cause for elevated systemic venous pres-
sure. One patient in our series had a narrowing in the Fontan
baffle that was addressed with a stent; however, the clinical
features of PLE persisted until an atrial pacemaker was
implanted.
The resolution of clinical and laboratory PLE in these 2
patients after atrial pacing is likely a result of augmented car-
diac output. Sinus node dysfunction may limit cardiac output
through loss of the atrial contribution to ventricular filling.
Although the results of a surgically created fenestration in the
Fontan baffle have been acceptable with regard to PLE, it
may leave the patient prohibitively cyanosed. Atrial pacing is
an alternative way to increase cardiac output without the
hypoxemia associated with the fenestration. The 2 patients in
our report had sinus node dysfunction in addition to PLE. It
is unknown whether other patients with PLE, but without
sinus node dysfunction, would similarly benefit from the
salutary effects of atrial pacing and increased cardiac output.
Atrial pacing should be considered as part of the treatment
regimen for patients with PLE after the Fontan operation.
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